Next Generation Approach

The increasing fear of drug-resistant superbugs is leading to a growing push for the next generation of antibiotics. The development of new antibiotics is crucial to controlling current and future infectious diseases caused by antibiotic-resistant bacteria. The discovery of a new antibiotic called teixobactin was announced by international team of researchers in 2017. The researchers now plan on studying the bacteria and decide what tools might be able to control its behavior to release its full antibiotic potential. An expected 5– 10% of all hospitalizations are perplex by a nosocomial disease with an expected cost of $4.5– 5.7 billion every year in the USA alone. More varieties of biological solution are yet to be discovered in this field.

 

  • Bacterial Biofilms
  • Oral Antibiotic Therapy
  • Combination Therapy
  • Empiric Antibiotic Therapy
  • Molecular Epidemiology

Related Conference of Next Generation Approach

November 21-22, 2019

World Conference on Vaccine and Immunology

MENA Plaza Hotel Albarsha | Dubai, UAE
November 21-22, 2019

14th International Conference on Allergy and Clinical Immunology

Courtyard by Marriot Bali Seminyak Resort | Bali, Indonesia
December 02-03, 2019

10th International Conference on Immunology & Immunogenetics

Park Inn by Radisson Hotel & Conference Centre London
June 23-24, 2020

34th World Congress on Vaccines and Immunization

Osaka, Japan
September 14-15, 2020

35th World Congress on Immunology

Tokyo, Japan
Oct 12-13, 2020

International Conference on Vaccine and Vaccine Research

Manila, Philippines
October 14-15, 2020

13th International Conference on Allergy & Immunology

Zurich, Switzerland
October 19-20, 2020

lifestylemanagment-cs-2020

Amsterdam, Netherlands

International Conference on Immunology & Immunotherapies

November 18-19, 2020 | Bangkok, Thailand
November 25-26, 2020

International Conference On European Immunology

London, UK

Next Generation Approach Conference Speakers

Recommended Sessions

Related Journals

Are you interested in